#NovoNordisk #GLP1Drugs #DrugSafety
www.aol.com
FDA: Novo Nordisk failed to report deaths of weight-loss drug patients
The manufacturer of popular weight-loss drugs Ozempic and Wegovy, Novo Nordisk, is taking heat from the federal government for regularly failing to report potential side effects of its GLP-1 medications, including deaths.
#GLP1drugs #Addiction #SubstanceUseDisorders
www.yahoo.com
What to know about how GLP-1 medications might fight addiction
Add Yahoo as a preferred source to see more of our stories on Google.
The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders -- and reduce the tragic outcomes they cause, a large new study finds.
#HealthRisks #Osteoporosis #GLP1Drugs
ca.style.yahoo.com
GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds
Add Yahoo as a preferred source to see more of our stories on Google.
Taking popular GLP-1 class weight loss drugs like Ozempic and Wegovy could be linked to a higher risk of developing osteoporosis, gout and a condition that causes severe bone softening compared to people who don't use the medications, researchers said Monday.
